Ji-Won Kim
Net worth: 38 627 $ as of 30/06/2026
Net worth: 38 627 $ as of 30/06/2026
Ji-Won Kim currently works at Aju IB Investment Co., Ltd. (Private Equity), as Chief Executive Officer, AJU IB Investment Co., Ltd., as Chief Executive Officer & Director from 1999, and SL VaxiGen, Inc., as Director.
Mr. Kim received his undergraduate degree from Yonsei University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 10/06/2026 | 12,416 ( 0.01% ) | 38 627 $ | 30/06/2026 |
| Companies | Position | Start |
|---|---|---|
| AJU IB INVESTMENT CO., LTD. | Chief Executive Officer | 01/01/1999 |
Aju IB Investment Co., Ltd. (Private Equity)
Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB is a long-term investor focused on high technology Korean companies with significant growth potential. Aju IB's investment criteria include management's capability, ethics and transparency, potential market leadership or ability to control the market, technological barriers to entry, significant market size, profitability and maturity. They also take into consideration portfolio diversification. | Chief Executive Officer | - |
SL VaxiGen, Inc.
SL VaxiGen, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures vaccine therapeutics | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Yonsei University
Yonsei University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aju IB Investment Co., Ltd. (Private Equity)
Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB is a long-term investor focused on high technology Korean companies with significant growth potential. Aju IB's investment criteria include management's capability, ethics and transparency, potential market leadership or ability to control the market, technological barriers to entry, significant market size, profitability and maturity. They also take into consideration portfolio diversification. | Finance |
AJU IB Investment Co., Ltd.
AJU IB Investment Co., Ltd. Investment ManagersFinance Invests in venture and new technology businesses | Finance |
SL VaxiGen, Inc.
SL VaxiGen, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures vaccine therapeutics | Health Technology |
Select your edition
All financial news and data tailored to specific country editions